/
and Strategy Our purpose is to bring the power of biotherapeutics to the whole body, including the brain, by discovering, developing, and delivering medicines for people living with serious diseases. Historically, the blood-brain barrier has been a major challenge to the development of medicines for diseases of the central nervous system.
ROIC dropped from -32.53% to -37.50%, capital efficiency is deteriorating. Negative free cash flow of -$422M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (FY)
$0.00
Net Income (TTM)
-$508M
▼ -21.2% YoY
Op. Margin
—
ROIC
-42.50%
▼ -5.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$419M
▼ -16.1% YoY
Op. Cash Flow (TTM)
-$412M
▼ -18.7% YoY
Net Debt
-$948M
Net Cash Position
Cash & Equiv.
$988M
Continue Research